Purchases and Sales Made in Q3 2024 in Nls Pharmaceutics LTD Wt Pur C (NLSPW)
This table provides information about the institutional ownership of Nls Pharmaceutics LTD Wt Pur C (NLSPW) during Q3 2024. The information is specifically focused on institutions that hold shares of NLS PHARMACEUTICS LTD WT PUR C.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
3.62K+ 22.6% |
$36.2 - $181
|
19.6K
$196
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Clear Street LLC
|
SELL
|
- |
-29- 0.35% |
$0.29 - $1.45
|
8.24K
$82.4
|
|
|
Nov 13, 2024
Q3 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-28.6K- 28.64% |
$286 - $1.43K
|
71.4K
$714
|
|
|
Nov 14, 2024
Q3 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-488K- 97.5% |
$4.88K - $24.4K
|
12.5K
$125
|